Febuxostat Versus Allopurinol Streamlined Trial (FAST): Comparing the effects of two different treatments for gout
FAST (Gout research) - Streamlined Trial (FAST) comparing the effects of two different treatments for gout.
Why are we doing this study?: FAST is a safety study, requested by the EMEA, of Febuxostat versus standard urate lowering therapy with allopurinol for chronic symptomatic Hyperuricaemia.
Which patients can take part?: Potential patients are identified from the computer databases of participating general practices. For those patients who express an interest, FAST research nurses will conduct patient interviews, provide patients with information about FAST, obtain informed consent from patients willing to participate, and carry out all the initial data entry and associated administration. if you have gout and would like to enquire about this research please contact the relevant FAST (Gout) contact below. It’s free to ask for some details from FAST and they would be happy to talk to you.